Terapias complementarias en migraña y variables relacionadas. Encuesta Europea

Terapias complementarias en migraña y variables relacionadas. Encuesta Europea Complementary therapies in migraine and related variables. European Survey

Published 2021-04-29 — Updated on 2022-02-17


https://doi.org/10.30554/archmed.21.2.4138.2021
Open | Download
PDF (Spanish) FLIP HTML (Spanish) epub (Spanish) XML (Spanish)
Issue
Vol. 21 No. 2 (2021): .
Section
Artículos de Investigación
How to Cite
Vicente Herrero, M. T., Ramírez-Iñiguez-de-la-Torre, M. V. ., Ruiz de la Torre, E. ., & Reinoso Barbero, L. . (2022). Terapias complementarias en migraña y variables relacionadas. Encuesta Europea: Complementary therapies in migraine and related variables. European Survey. Archivos De Medicina , 21(2). https://doi.org/10.30554/archmed.21.2.4138.2021 (Original work published 2021)
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX
DOI

https://doi.org/10.30554/archmed.21.2.4138.2021
Dimensions
PlumX

How to Cite

Vicente Herrero, M. T., Ramírez-Iñiguez-de-la-Torre, M. V. ., Ruiz de la Torre, E. ., & Reinoso Barbero, L. . (2022). Terapias complementarias en migraña y variables relacionadas. Encuesta Europea: Complementary therapies in migraine and related variables. European Survey. Archivos De Medicina , 21(2). https://doi.org/10.30554/archmed.21.2.4138.2021 (Original work published 2021)

Download Citation

license
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

María Teófila Vicente Herrero
Servicio de Prevención de Riesgos Laborales.
https://orcid.org/0000-0002-0796-9194 ORCID
María Victoria Ramírez-Iñiguez-de-la-Torre
Servicio de Prevención de Riesgos Laborales. Correos. Albacete, España. 
https://orcid.org/0000-0002-7772-5689 ORCID
Elena Ruiz de la Torre
European Migraine and Headache Alliance
https://orcid.org/0000-0003-1324-3100 ORCID
Luis Reinoso Barbero
Especialista en Medicina del Trabajo. Servicio de Prevención de Riesgos Laborales.
https://orcid.org/0000-0001-8761-6382 ORCID
Show authors biography

María Teófila Vicente Herrero,

Doctora en Medicina. Especialista en Medicina del Trabajo. Servicio de Prevención de Riesgos Laborales. Correos. Valencia, España. 

María Victoria Ramírez-Iñiguez-de-la-Torre,

Doctora en Medicina. Especialista en Medicina del Trabajo. Servicio de Prevención de Riesgos Laborales. Correos. Albacete, España. 

Elena Ruiz de la Torre,

Executive Director. Past President. European Migraine and Headache Alliance. 

Luis Reinoso Barbero,

Doctor en Medicina. Especialista en Medicina del Trabajo. Servicio de Prevención de Riesgos Laborales. Banco de Santander. Madrid, España. O

Most read articles by the same author(s)

Summary

Migraine affects one of every ten people worldwide, with an increasing and higher prevalence among women in urban areas. Although the usual treatments are pharmacological, the use of alternative techniques increases. This study aim is to assess the influence of socio-demographic variables on the characteristics of migraine in European countries and the use of non-pharmacological alternative therapies.

Cross-sectional observational study by anonymous web survey to 3,342 patients from European countries. Study variables: age, gender, country, type of location, level of studies, and rural or urban area and the response to: Do you use other complementary treatments? (diets, physiotherapy, mindfulness ...): Yes, No.

Type, duration and migraine frequency are related to age, gender and cultural factors. Its distribution and characteristics differ according to the European countries studied.

The use of alternative therapies in migraine is a growing phenomenon, with greater use in patients between 41-60 years and higher education.

Article visits 565 | PDF visits 382

Downloads

Download data is not yet available.
  1. Woldeamanuel YW, Cowan RP. Migraine affects
  2. in 10 people worldwide featuring recent rise:
  3. A systematic review and meta-analysis of community-
  4. based studies involving 6 million participants.
  5. J Neurol Sci. 2017; 372:307-315.
  6. DOI: 10.1016/j.jns.2016.11.071
  7. Wang X, Zhou HB, Sun JM, Xing YH, Zhu YL, Zhao
  8. YS. The prevalence of migraine in university
  9. students: a systematic review and meta-analysis.
  10. Eur J Neurol. 2016; 23(3):464-475.
  11. https://doi.org/10.1111/ene.12784
  12. Robbins MS, Lipton RB. The epidemiology of primary
  13. headache disorders. Semin Neurol. 2010;
  14. (2):107-119.
  15. http://dx.doi.org/10.1055/s-0030-1249220
  16. Kamm K, Ruscheweyh R, Eren O, Straube A. The
  17. Classification of Headache: Important Aspects of
  18. Patient’s History and Clinical Diagnostic. Dtsch
  19. Med Wochenschr. 2017; 142(6):409-417.
  20. DOI: 10.1055/s-0042-116383
  21. Carbaat PA, Couturier EG. Headache: classification
  22. and diagnosis. Ned Tijdschr Tandheelkd. 2016;
  23. (11):539-544. DOI: 10.5177/ntvt.2016.11.16122
  24. Rizzoli P, Mullally WJ. Headache. Am J Med. 2018;
  25. (1):17-24. DOI: 10.1016/j.amjmed.2017.09.005
  26. Cuéllar Rodríguez S. Migraña. Panorama Actual
  27. Med. 2018; 42(415):634-653.
  28. Millstine D, Chen CY, Bauer B. Complementary
  29. and integrative medicine in the management of
  30. headache. BMJ. 2017; 357:1-3.
  31. DOI: 10.1136/bmj.j1805
  32. Vicente-Herrero MT, Ruiz-de la Torre E, Reinoso
  33. Barbero L. Trabajo y migraña. Encuesta europea.
  34. Medicina Balear. 2019; 34(3):30-37.
  35. DOI: 10.3306/MEDICINABALEAR.34.03.30
  36. Vicente-Herrero MT, Ramírez-Iñiguez-de-la-Torre
  37. MV, Capdevila-García L. Asociación Española de
  38. Especialistas en Medicina del Trabajo (AEEMT).
  39. Resumen de conclusiones. Encuesta Europea
  40. Trabajo y Migraña. Madrid: EMHA; 2019.
  41. Buse DC, Loder EW, Gorman JA, Stewart WF, Reed
  42. ML, Fanning KM, et al. Sex differences in the
  43. prevalence, symptoms, and associated features
  44. of migraine, probable migraine and other severe
  45. headache: results of the American Migraine Prevalence
  46. and Prevention (AMPP) Study. Headache.
  47. ; 53(8):1278-99.
  48. Buse D, Manack A, Serrano D, Reed M, Varon S,
  49. Turkel C, et al. Headache impact of chronic and
  50. episodic migraine: results from the American
  51. Migraine Prevalence and Prevention study.
  52. Headache. 2012; 52(1):3-17.
  53. DOI: 10.1111/j.1526-4610.2011.02046.x
  54. Befus DR, Irby MB, Coeytaux RR, Penzien DB.
  55. A Critical Exploration of Migraine as a Health
  56. Disparity: the Imperative of an Equity-Oriented,
  57. Intersectional Approach. Curr Pain Headache
  58. Rep. 2018; 22(12):79.
  59. DOI: 10.1007/s11916-018-0731-3
  60. Müller KI, Alstadhaug KB, Bekkelund SI. Acceptability,
  61. Feasibility, and Cost of Telemedicine for
  62. Non acute Headaches: A Randomized Study
  63. Comparing Video and Traditional Consultations.
  64. J Med Internet Res. 2016; 18(5):e140.
  65. DOI: 10.2196/jmir.5221
  66. Wells RE, Baute V, Wahbeh H. Complementary and
  67. Integrative Medicine for Neurologic Conditions.
  68. Med Clin North Am. 2017; 101(5):881-93.
  69. DOI: 10.1016/j.mcna.2017.04.006
  70. Wells RE, Beuthin J, Granetzke L. Complementary
  71. and Integrative Medicine for Episodic Migraine:
  72. an Update of Evidence from the Last 3 Years.
  73. Curr Pain Headache Rep. 2019; 23(2):10.
  74. DOI: 10.1007/s11916-019-0750-8
  75. Wen Y, Wang D, Fan G. Acupoint selection
  76. for acute migraine treated with acupuncture.
  77. Zhongguo Zhen Jiu. 2018; 38(11):1183-8.
  78. DOI: 10.13703/j.0255-2930.2018.11.013
  79. Andrasik F, Grazzi L, Sansone E, D’Amico D, Raggi
  80. A, Grignani E. Non-pharmacological Approaches
  81. for Headaches in Young Age: An Updated Review.
  82. Front Neurol. 2018; 9:1009.
  83. DOI: 10.3389/fneur.2018.01009
  84. Grazzi L, Sansone E, Raggi A, D’Amico D, De
  85. Giorgio A, Leonardi M, et al. Mindfulness and
  86. pharmacological prophylaxis after withdrawal
  87. from medication overuse in patients with Chronic
  88. Migraine: an effectiveness trial with a one-year
  89. follow-up. J Headache Pain. 2017; 18(1):15.
  90. DOI: 10.1186/s10194-017-0728-z
  91. Grazzi L, D’Amico D, Raggi A, Leonardi M, Ciusani
  92. E, Corsini E, et al. Mindfulness and pharmacological
  93. prophylaxis have comparable effect on
  94. biomarkers of inflammation and clinical indexes
  95. in chronic migraine with medication overuse:
  96. results at 12 months after withdrawal. Neurol
  97. Sci. 2017; 38(Suppl 1):173-75.
  98. DOI: 10.1007/s10072-017-2874-0
  99. Oberg EB, Rempe M, Bradley R. Self-directed
  100. Mindfulness Training and Improvement in Blood
  101. Pressure, Migraine Frequency, and Quality of
  102. Life. Glob Adv Health Med. 2013;2(2):20-5.
  103. DOI: 10.7453/gahmj.2013.006
  104. Literatura citada
  105. Archivos de Medicina Volumen 21 Nº 2 - Julio-Diciembre de 2021
  106. Universidad de Manizales - Facultad de Ciencias de la Salud
  107. Probyn K, Bowers H, Mistry D, Caldwell F, Underwood
  108. M, Patel S, et al. Non-pharmacological
  109. self-management for people living with migraine
  110. or tension-type headache: a systematic review
  111. including analysis of intervention components.
  112. BMJ Open. 2017; 7(8):e016670.
  113. DOI: 10.1136/bmjopen-2017-016670
  114. Tavallaei V, Rezapour-Mirsaleh Y, Rezaiemaram P,
  115. Saadat SH. Mindfulness for female outpatients
  116. with chronic primary headaches: an internet-
  117. based bibliotherapy. Eur J Transl Myol. 2018;
  118. (2):7380. DOI: 10.4081/ejtm.2018.7380
  119. Wells RE, Burch R, Paulsen RH, Wayne PM, Houle
  120. TT, Loder E. Meditation for migraines: a pilot
  121. randomized controlled trial. Headache. 2014;
  122. (9):1484-95. DOI: 10.1111/head.12420
  123. Diener HC, Tassorelli C, Dodick DW, Silberstein SD,
  124. Lipton RB, Ashina M, et al. Guidelines of the International
  125. Headache Society for controlled trials
  126. of acute treatment of migraine attacks in adults:
  127. Fourth edition. Cephalalgia. 2019; 39(6):687-710.
  128. DOI: 10.1177/0333102419828967
  129. Rossi P, Di Lorenzo G, Malpezzi MG, Faroni J, Cesarino
  130. F, Di Lorenzo C, et al. Prevalence, pattern
  131. and predictors of use of complementary and
  132. alternative medicine (CAM) in migraine patients
  133. attending a headache clinic in Italy. Cephalalgia.
  134. ; 25(7):493-506.
  135. DOI: 10.1111/j.1468-2982.2005.00898.x

Information

Keywords

QR code

Sistema OJS 3.4.0.10 - Metabiblioteca |